Evidence map›Paper›PMID 41834353›Full record

ArticleJournal of the American Chemical Society2026

Expanding the Genetic Code with Lysine Aminoacylation.

Xinyu Li, Qinglei Gan, Chenguang Fan

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xinyu LiCell and Molecular Biology Program, University of Arkansas, Fayetteville, Arkansas 72701, United States.
Qinglei GanDepartment of Chemistry and Biochemistry, University of Arkansas, Fayetteville, Arkansas 72701, United States.
Chenguang FanCell and Molecular Biology Program, University of Arkansas, Fayetteville, Arkansas 72701, United States.ORCID 0000-0003-0662-1185

Funding

Studying lysine aminoacylation of human metabolic enzymesR15GM159279 · NIGMS · UNIVERSITY OF ARKANSAS AT FAYETTEVILLE · PI FAN, CHENGUANG · 2025 to 2025
$563k
NIGMS NIH HHS R15 GM159279
6 · The paper itself

Abstract

Lysine aminoacylation is a newly discovered protein post-translational modification that is found in humans. However, few studies have been implemented to further investigate its function, possibly due to limited tools to produce target proteins with homogeneously aminoacylated lysine residues at specific sites. To achieve this goal, we applied the genetic code expansion strategy, engineered pyrrolysyl-tRNA synthetase, and established orthogonal translation systems for ten types of lysine aminoacylation compatible for both bacterial and mammalian cells. Because metabolic enzymes are preferred substrate proteins of lysine aminoacylation, we tested the effect of lysine aminoacylation on metabolic enzymes and demonstrated that lysine valylation and tyrosylation impaired pyruvate kinase and glucose-6-phosphate dehydrogenase activities, respectively. Further

Indexed as

Genetic CodeLysineAminoacylationAmino Acyl-tRNA SynthetasesGlucosephosphate DehydrogenaseHumansPyruvate KinaseAmino Acyl-tRNA SynthetasesGlucosephosphate DehydrogenaseLysinePyruvate Kinase

Identifiers

PMID41834353
PMCPMC13022859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.